Leerink Swann Raises Revenue, EPS Estimates for Illumina
April 08, 2011
Leerink Swann Raises Revenue, EPS Estimates for Illumina
Analyst Dan Leonard said growth will be driven by what he expects to be record-breaking sales of Illumina's next-generation sequencing platforms, including its HiSeq, in the first and second quarters of 2011.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.